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Ethnopharmacological relevance: Maytenus robusta Reissek (Celastraceae) is traditionally used in Brazilian
folk medicine to treat gastric ulcer, as a substitute for M. ilicifolia, which is almost extinct. The gastro-
protective properties of M. robusta were demonstrated previously using only preventive approaches,
such as acute gastric ulcer models. However, the healing effect of M. robusta in gastric ulcers remains
unclear.
Aim of the study: The current study was carried out to investigate the healing effectiveness of M. robusta
hydroalcoholic extract (HEMR) from aerial parts in the acetic acid-induced chronic ulcer model and to
determine its effect on cell proliferation, scavenging free radicals, and inﬂammatory and oxidative da-
mage.
Material and methods: To evaluate the healing properties of HEMR in vivo, chronic gastric ulcer was
induced in rats by 80% acid acetic. Next, different groups of animals (n¼6) were treated orally with
vehicle (water plus 1% tween, 1 ml/kg), omeprazole (20 mg/kg), or HEMR (1–10 mg/kg), twice daily for
7 days. At the end of the treatment, the total ulcer area (mm2) was measured and a sample of gastric
tissue was taken for histological and histochemical analysis. Evaluation of GSH and LOOH levels, GST,
SOD, CAT and MPO activity was also performed at the site of the lesion. In parallel, radical scavenging
activity, cytoprotective effect, and cell proliferation activity in ﬁbroblasts (L929 cells) were determined by
in vitro trials. The antisecretory properties were evaluated using the pylorus ligature model in rats, and
the anti-Helicobacter pylori activity was determined in vitro. Acute toxicity was evaluated by relative
organ weight and biochemical parameters in serum. The prokinetic properties were also evaluated in
mice.
Results: Oral administration of HEMR (10 mg/kg) reduced the gastric ulcer area by 53%, compared to the
vehicle group (120.078.3 mm2), the regeneration of gastric mucosa was evidenced in histological
analysis. Moreover, HEMR treatment increased gastric mucin content and reduced oxidative stress and
inﬂammatory parameters at the site of the ulcer. In vitro, HEMR (1–1000 mg/ml) was able to scavenge
free radical DPPH and promote cytoprotection against H2O2 in ﬁbroblasts at 0.1–100 mg/ml. Moreover,
HEMR healing properties also were conﬁrmed by enhancement of proliferation and coverage of scrat-
ched wounds in ﬁbroblast monolayer. However, HEMR (10 mg/kg) by the intraduodenal route did not
promote changes in volume, pH, total acidity or pepsin activity in the pylorus ligature model, and HEMR
up to 2000 mg/ml also did not present considerable activity against H. pylori. In relation to gastro-
intestinal motility, HEMR (10 mg/kg, p.o) did not provoke alterations. It is also important to mention that
oral administration of HEMR did not produce any sign of acute toxicity in animals.rved.
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L. Mota da Silva et al. / Journal of Ethnopharmacology 175 (2015) 75–8576Conclusions: The data here obtained show that M. robusta has evident ulcer healing potential, mainly
through the strengthening of protective factors of gastric mucosa, such as mucus layer, antioxidant de-
fenses and cell proliferation. Taking into account the advantages of cultivation and harvesting of M.
robusta compared to M. ilicifolia, and the evidence presented here, it is plausible to conclude that hy-
droalcoholic extract obtained from aerial parts of M. robusta is an interesting source for the development
of a phytotherapeutic formulation to treat gastric ulcer.
& 2015 Elsevier Ireland Ltd. All rights reserved.1. Introduction
Maytenus robusta Reissek (cafezinho do mato or coração de bu-
gre) is used in traditional folk medicine to gastric ulcer (Balbach,
1980; Cunha, 2003, Niero et al., 2011). Similarly to other Maytenus
sp, the traditional use of M. robusta consist on the intake of its
decoction or infusion, prepared with dry and pulverized leaves, up
to four times per day (Teske and Trentini, 2001). Based on this, our
research group has attempted to ﬁnd a scientiﬁc basis for the
development of an alternative phytotherapeutic formulation pre-
pared from M. robusta, given that this species is very well adapted
to the South of Brazil (Niero et al., 2001). In addition to its tradi-
tional use, harvesting of M. robusta is favored because this species
is a medium-sized tree with a dense crown, and its leaves have no
thorns, unlike those of M. ilicifolia. It is therefore suitable for sus-
tainable cultivation in order to obtain standardized phytotherapic
preparations. Previously, the gastroprotective properties of M. ro-
busta were demonstrated by Andrade et al. (2007, 2008) using
only preventive approaches, such as acute gastric ulcer models.
However, the healing effect of M. robusta in gastric ulcer remains
unclear, and it is important to emphasize that conﬁrmation of
gastroprotective activity is not necessarily an indication of healing
activity on existing gastric ulcers (Vasconcelos et al., 2008; Périco
et al., 2015).
Gastric ulcer is a lesion characterized by necrosis, neutrophil
inﬁltration, reduction in blood ﬂow, increased oxidative stress, and
inﬂammation (da Silva et al., 2013). It occurs due to an imbalance
between aggressive injurious factors (pepsin, HCl) and defensive
mucosa-protective factors (prostaglandins, mucus and bicarbonate
barrier and adequate blood ﬂow) (Tygat, 2011). Besides, stress
(Levenstein et al., 2014), smoking, nutritional deﬁciencies (Duggan
and Duggan, 2006), prolonged ingestion of nonsteroidal-anti-in-
ﬂammatory drugs (NSAIDs) (Belaiche et al., 2002), and Helico-
bacter pylori infection (Beltrán-Anaya et al., 2014) are all relevant
etiological factors for the development of gastric ulcer.
Currently the treatment of gastric ulcer is based on the in-
hibition of gastric acid secretion by H2-antagonists, such as rani-
tidine; or proton-pump inhibitors, such as omeprazole (De Vault
and Talley, 2009). However, the main problem is that despite a
healing rate, ulcers treated with H2-antagonists and proton pump
inhibitors can present recurrence within 1 year after the end of
treatment (Kangwan et al., 2014). This is mainly due to neutrophil
accumulation and ROS production, resulting in an incomplete
healing process (Tarnawski et al., 1990). Furthermore, side effects
such as osteoporosis (Panday et al., 2014), hypergastrinemia and
hyperplasia of enterochromafﬁn-like cells (ECL) (Sheen and Tria-
daﬁlopoulos, 2011) are common in the prolonged therapy with
antisecretory drugs.
In view of the above, the search for new antiulcer treatments is
essential, focusing mainly on the search for agents that promote
effective healing of gastric ulcer. The present study was carried out
using the acetic acid-induced chronic gastric ulcer as an experi-
mental model. This model is highly similar to human ulcers in
terms of pathological aspects and healing process. Consequently,this model is an appropriate tool to evaluate the gastric ulcer
healing process of different substances in the gastric tissue (Okabe
and Amagase, 2005). The aim of the study was to investigate the
effectiveness of healing activity of Maytenus robusta hydroalco-
holic extract from aerial parts in the acetic acid-induced chronic
ulcer model, and to determine its effect on cell proliferation,
scavenging free radicals, and inﬂammatory and oxidative damage
regulation.2. Materials and methods
2.1. Drugs and reagents
The following substances were used: Bovine serum albumin,
2,2-diphenyl-1-picrylhydrazyl, 5,5′-dithiobis (2-nitrobenzoic acid),
glutathione, MTT, omeprazole, pyrogallol, xylenol orange (all from
Sigma, St. Louis, USA), absolute ethanol, acetic acid, ascorbic acid,
hydrochloric acid, diethyl ether, formaldehyde, hydrogen peroxide,
magnesium chloride, methanol, sodium acetate, sodium carbo-
nate, sucrose, trichloroacetic acid (Vetec, Rio de Janeiro, RJ, Brazil),
dimetilsufoxide and N,N-dimethylformamide (DMSO, Synth, Dia-
dema, SP, Brazil), Dulbecco’s Modiﬁed Eagle Medium (DMEM, Vi-
trocell, Campinas, SP, Brazil), and fetal bovine serum (FBS, Gibco).
2.2. Plant material and preparation of the extract
Maytenus robusta was collected at the Morro do Baú Ecological
Park, Ilhota, Santa Catarina, and identiﬁed by Dr. Ademir Reis
(Department of Botany, Universidade Federal de Santa Catarina). A
voucher specimen was deposited at the Barbosa Rodrigues Her-
barium (Itajaí-SC), and identiﬁed as V.C. Filho 016.
Brieﬂy, air-dried and ground leaves (500 g) were macerated in
70% aqueous ethanol (v/v) at room temperature for 7 days, as
described previously (Andrade et al., 2007). The macerated leaves
were then ﬁltered, and the solvent was eliminated under reduced
pressure. The dried material yielded 38.0 g (7.6%) of the crude
hydroalcoholic extract of M. robusta (HEMR). The phytochemical
proﬁle of the extract used in this work was studied previously, and
the main compounds present were identiﬁed as pentacyclic tri-
terpenes (Niero et al., 2001, 2006; Andrade et al., 2008).
2.3. Animals
The ulcer experiments were conducted with female Wistar rats
(2–3 months, 180–200 g). Swiss female mice (8 weeks, 20–25 g)
were used in the gastric emptying and intestinal experiments. The
animals were provided by the Universidade do Vale do Itajaí col-
ony and maintained under standard laboratory conditions (12 h
light/dark cycle, temperature of 2272 °C) with free access to
standard pellet food (Biobase, Águas Frias/SC, Brazil) and water.
The animals were deprived of food (12 h) prior to the experiments.
All the experiments were performed after approval by the In-
stitutional Animal Ethics Committee of Universidade do Vale do
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ducted in accordance with the “Principles of Laboratory Animal
Care” (NIH Publication 85-23, revised 1985).
2.4. Evaluation of healing properties
2.4.1. Acetic acid-induced gastric ulcer
Chronic gastric ulcers were induced in rats by the method of
Okabe et al. (1971), with slight modiﬁcations. Rats were rando-
mized into ﬁve groups, with six rats per group. First, the animals
were anaesthetized with xylazine/ketamine (7.5 mg/kg and
60 mg/kg, i.p) and a laparotomy was performed to expose the
stomach. Thereafter, 500 μl 80% acetic acid (v/v) was instilled via a
plastic tube of 6 mm diameter, which was applied to the serosal
surface of the stomach for 1 min. The acetic acid was aspirated and
the area was washed with sterile saline. The treatment period was
started on the second day after ulcer induction. Animals were
treated orally with vehicle (water plus 1% tween, 1 mL/kg), ome-
prazole (20 mg/kg, an inhibitor of gastric Hþ , Kþ-ATPase and
positive control), or HEMR (1, 3 and 10 mg/kg), twice daily for
7 days. Omeprazole and HE were dissolved immediately before
oral administration in water plus 1% tween. Animals were sacri-
ﬁced on the day following the last treatments; their stomachs
were removed and opened along the great curvature. The length
(mm)width (mm) of ulcer was measured using a ruler to assess
the total ulcer area (mm2).
2.4.2. Histological and histochemical analysis
The gastric ulcers induced by acetic acid in rats submitted to
different treatments were located, sectioned, and ﬁxed in ALFAC
solution (85% alcohol 80°GL, 10% formaldehyde at 40% and 5%
glacial acetic acid). The samples were then dehydrated with al-
cohol and xylene and embedded in parafﬁn wax, and sectioned at
5 μm for histological evaluation after hematoxylin/eosin and Per-
iodic Acid–Schiff (PAS) staining as described by Maria-Ferreira
et al. (2014). Histological analysis of the gastric sections was car-
ried out using a stereoscopic microscope with magniﬁcation of
10 . Periodic acid–Schiff (PAS)-stained mucin-like glycoproteins
positive pixels were quantiﬁed using ImageJs software in a mag-
niﬁcation of 400 .
2.4.3. Cell culture
The murine ﬁbrosarcoma L929 (NCTC clone 929) cell line was
purchase from the Rio de Janeiro cell bank. The cells were cultured
in Dulbecco’s Modiﬁed Eagle Medium (DMEM) supplemented
with 10% fetal bovine serum (FBS) in 5% CO2, with humidiﬁed at-
mosphere, at 37 °C. The experiments were performed when the
cells had reached about 90% of conﬂuence.
2.4.4. Cell viability assay (MTT)
L929 cells (1105) were cultured in 96-well plates (in tripli-
cates) in the presence of a vehicle (culture medium with 0.1% of
DMSO), 10% DMSO (control) or M. robusta extract (0.1, 1 or
10 μg/mL) at 37 °C for 24 h. MTT (0.5 mg/mL) was added to cells,
the cultures were incubated for 3 h at 37 °C, and the absorbance
was analyzed at 570 nm after solubilization of reduced formazan
crystals with pure DMSO (Chen et al., 2003). The percentage of cell
viability was calculated as the ratio (Abs. sampleAbs. blank/Abs.
vehicle100).
2.4.5. Cell proliferation activity
The proliferation ability of ﬁbroblasts exposed to HEMR was
assessed using the scratch wound assay as previously described by
Balekar et al. (2012) with few modiﬁcations, which measures the
expansion of a cell population on surfaces. Monolayers of L929
cells were allowed to form in a 24-well plate containing anenriched medium of DMEM/10% FBS. When nearly conﬂuent, the
plate was taken out and artiﬁcial wounds were created in the
monolayers by making a linear scratch in the center of each well
using the tip of a sterile 200 mL plastic pipette tip. Any cellular
debris created from the scratch was removed by gently washing
the wells with phosphate buffered saline (PBS).
Once ready, the scratched wounds were divided into groups.
The cells were treated with a lower (0.1 mg/ml) or a high (1 mg/ml)
concentration of HEMR, DMEM/5% FBS was used as negative
control. The plates were then incubated at 37 °C in a humidiﬁed
incubator with 5% CO2 atmosphere. The plates were evaluated
after 30 h of incubation to assess the closure of the scratched
wounds. Micrographs were used to record the wound closure ac-
tivity, which was captured under an inverted microscope (Olym-
pus, CK40) with magniﬁcation of 100 . All the experiments were
performed in triplicate.
2.5. Preparation of subcellular fractions of stomachs
The stomachs were homogenized with 200 mM potassium
phosphate buffer (pH 6.5). The homogenate was used to determine
the reduced glutathione (GSH) and then centrifuged at 9000g for
20 min. The supernatant was used to determine the activity of the
enzymes: glutathione S-transferase (GST), superoxide dismutase
(SOD) and catalase (CAT); the precipitate was used to determine
myeloperoxidase (MPO) activity.
2.6. Protein assay
Protein concentrations were determined by the Bradford
method (Bio-Rad, Hercules, CA, USA), using bovine serum albumin
(0.125–1.0 mg/mL) as standard, according to the manufacturer’s
instructions.
2.7. Evaluation of antioxidant properties
2.7.1. Determination of GSH levels
GSH levels in gastric mucosa were determined by the method
of Sedlak and Lindsay (1968). Aliquots of tissue homogenate were
mixed with 12.5% trichloroacetic acid, for 10 min, and centrifuged
for 15 min at 900g. Thereafter, the supernatants were mixed with
TRIS buffer (0.4 M, pH 8.9) and 5,5,9-dithiobis (2-nitrobenzoic
acid) (DTNB, 0.01 M) and the absorbance was measured by spec-
trophotometry at 415 nm. The procedures were performed at 4 °C,
and the individual values were interpolated into a standard curve
of GSH (1.25–10 mg/mL) and expressed as mg/g of tissue.
2.7.2. Determination of GST activity
The total GST activity was determined as described by Habig
et al. (1974). Brieﬂy, reactions were carried out in the presence of
supernatant aliquots, 1 mM 1-chloro-2,4-dinitrobenzene (CDNB),
1 mM GSH and 100 mM potassium phosphate buffer (pH 6.5) at
room temperature. The reaction of CDNB with GSH was monitored
at 340 nm for 90 s. Speciﬁc activity was calculated using an ex-
tinction coefﬁcient of 9.6/mM/cm for GSH, and the results were
expressed as mmol/min/mg of protein.
2.7.3. Determination of SOD activity
SOD activity was measured based on the ability of the enzyme
to inhibit the process of pyrogallol autoxidation, according to
Marklund and Marklund (1974) and Gao et al. (1998). Supernatant
aliquots were added to buffer solution (200 mM Tris HCl–EDTA,
pH 8.5) and pyrogallol (1 mM), and then mixed for 1 min. The
reaction was incubated for 20 min at room temperature, stopped
with the addition of 1 N HCl and centrifuged for 4 min at 18,700g.
The absorbance of the resulting supernatant was measured at
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ogallol by 50%, relative to the control, was deﬁned as one unit of
SOD activity. The SOD activity was expressed as U/mg of protein.
2.7.4. Determination of CAT activity
CAT activity was deﬁned as the amount of enzyme required to
decompose 1 μmol of H2O2 per minute at 25 °C and pH 7.0 and
measured by adding supernatant aliquots to buffer solution
(200 mM Tris HCl–EDTA, pH 8.5) containing 20 mM H2O2, as
previously described by Aebi (1984). The enzymatic activity was
immediately determined spectrophotometrically at 240 nm and
the results were expressed as μmol/min/mg protein.
2.7.5. Determination of lipoperoxide content (LOOH)
The lipid peroxidation content was determined using the
method of Ferrous Oxidation-Xylenol Orange (FOX2), as described
by Jiang et al. (1992). Brieﬂy, 30 ml of 90% methanol was added to
100 ml of homogenate, mixed and centrifuged at 9000g for 20 min
at 4 °C. Next, the supernatant was added to FOX2 reagent [4 mM
butylated hydroxytoluene (BHT), 250 mM FeSO4, 25 mM H2SO4
and xylenol orange at 100 mM] and incubated for 30 min at room
temperature. The absorbance was determined at 560 nm and the
concentration of LOOH was equalized to 1 mg of tissue. The results
were expressed as mmol/mg of tissue using the extinction coef-
ﬁcient of 43.6/M/cm for H2O2, cumene hydroperoxide or butyl
hydroperoxide.
2.7.6. In vitro study of radical scavenging activity-2,2-diphenyl-1-
picrylhydrazyl (DPPH) assay
The free radical scavenging ability of the HEMR was evaluated
by the decrease of DPPH absorbance, following Blois (1958) and
Chen et al. (2004), with a few modiﬁcations. Samples of HEMR (1,
10, 100 and 1000 mg/ml) were mixed with DPPH methanolic so-
lution (10 mg/ml). Ascorbic acid (50 mg/ml) was used as positive
control, and distilled water was used as negative control. The so-
lutions were mixed and incubated for 5 min at room temperature
and the absorbance was read at 517 nm. The individual values
were interpolated to a standard curve of DPPH (0–60 mM) and
expressed as μM de DPPH. All the experiments were performed in
triplicate.
2.7.7. Cytoprotective activity assay
In order to investigate of the protective effects of M. robusta
extract against H2O2 cytotoxicity, a co-treatment protocol was
used. Before treatment, the cells were seeded in DMEM containing
10% FBS in 96-well culture plates (5000 cells/well) and incubated
for 24 h at 37 °C. The cells where then simultaneously incubated
with different concentrations of HEMR extract (0.1, 1, 10 or
100 μg/mL) and 200 mM H2O2 for 2 h. Next, the medium was re-
placed with fresh DMEM containing 10% FBS and the cell viability
was quantiﬁed by MTT (Chen et al., 2003). All the experiments
were performed in triplicate.
2.8. Evaluation of gastric inﬂammatory parameters
2.8.1. Determination of in vivo MPO activity
Neutrophil inﬁltration in the ulcerated gastric mucosa was ac-
cessed by determining gastric MPO activity according to the
method described by Bradley et al. (1982) and modiﬁed by De
Young et al. (1989). Brieﬂy, the precipitate obtained from the ulcer
homogenate was mixed in 80 mM potassium phosphate buffer (pH
5.4) containing 0.5% hexadecyltrimethylammonium bromide
(HTAB), and centrifuged at 11,000g for 20 min at 4 °C. MPO activity
in the presence of H2O2 and 3, 3′, 5, 5′-tetramethylbenzidine
(TMB) in the supernatant was determined at 620 nm and ex-
pressed as units of milli optical density (mO.D.)/mg of protein.2.8.2. Determination of in vitro MPO activity
The in vitro MPO activity was determined using precipitate
from homogenated sample of ulcerated rats treated with vehicle,
which is a sample with high MPO activity, using the protocol de-
scribed above. The supernatants obtained were then incubated
with HEMR (1, 10 and 100 mg/ml) at room temperature for 15 min,
and the MPO activity was determined and expressed as previously
described. All the experiments were performed in triplicate.
2.8.3. In vivo leukocyte migration: air pouch model
Animals were anesthetized and 10 mL of sterile air was injected
subcutaneously into the dorsal region as described by Marinho
et al. (2011) with few modiﬁcations. After six days, the pouch was
reﬁlled with 10 mL air. On the tenth day following the ﬁrst air
injection, the animals were divided into groups and received one
of the following treatments by oral gavage: (1) Sham; (2) vehicle;
(3) indomethacin (30 mg/kg; positive control) or (4) HEMR
(10 mg/kg). After 1 h, carrageenan (1% PBS) was injected directly
into the pouches. Four hours after carrageenan injection, the ani-
mals were anesthetized and sacriﬁced. The pouches were washed
with 2 mL of ice-cold PBS, and the total leukocyte number was
determined using a Neubauer chamber. Differential cell counts
were performed on smears stained with May Grunwald-Giemsa.
2.9. Evaluation of antisecretory properties
2.9.1. Induction of hypersecretion by pylorus ligature in rats
Pylorus ligature was carefully performed in fasted rats under
anesthesia (Shay, 1945). Brieﬂy, to maintain the gastric content in
the stomach, the pylorus was located and ligated with sutures. The
animals were intraduodenally treated with vehicle (water plus 1%
tween, 1 ml/kg) or HEMR (10 mg/kg) immediately after pylorus
ligature. The positive control of the test was omeprazole (20 mg/
kg) administered by oral route 1 h before pylorus ligature. After
4 h of pyloric ligation, the animals were euthanized, the stomachs
opened, and the gastric secretion collected. Measurements of vo-
lume, pH and total gastric acidity were performed immediately
after collection, as described previously (Berté et al., 2014).
2.9.2. Peptic activity
The quantiﬁcation of pepsin activity was performed as de-
scribed by Anson (1938) in gastric content from rats submitted to
pylorus ligature and treated with vehicle (water plus 1% tween,
1 ml/kg), omeprazole (20 mg/kg) or HEMR (10 mg/kg) as described
above. Brieﬂy, 100 ml of gastric acid secretion was collected and
transferred to polypropylene tubes. The samples were added to
500 ml of bovine albumin solution (5 mg/ml in 0.06 M HCl) and
incubated at 37 °C for 10 min. Afterwards, the reaction was inter-
rupted by addition of 500 mL of 10% trichloroacetic acid, the sam-
ples were centrifuged at 1500g for 20 min, and the supernatant
was separated and alkalized with 5 ml of 0.55 M sodium carbo-
nate. Thereafter, 500 mL of 1 N Folin reagent was added to the
tubes and incubated for 30 min at room temperature. Next, 300 ml
from each tube was transferred to microplates and the absorbance
was determined at 660 nm. Individual values were interpolated on
a tyrosine standard curve (30–1000 mmol/mL) and the results
expressed as tyrosine μmol/ml/4 h.
2.10. Evaluation of prokinetic properties
Fasted female swiss mice were orally treated with vehicle (Veh:
water plus 1% tween, 1 ml/kg), atropine (Atro: 3 mg/kg, s.c.) or
HEMR (10 mg/kg, p.o) 30 min (s.c route) or 1 h (p.o route) prior to
administration of semisolid marker solution (0.05% phenol red
plus 1.5% carboxymethylcellulose), with the same volume in each
animal (0.5 mL). After 20 min, the mice were euthanized, and the
Fig. 1. Effects of HEMR on the chronic gastric ulcer induced by 80% acetic acid in
rats. The animals were orally treated with vehicle (Veh: water plus 1% tween, 1 ml/
kg), omeprazole (Ome: 20 mg/kg) or HEMR (1, 3 and 10 mg/kg) during 7 days. The
results are expressed as mean7S.E.M. (n¼8) and statistical comparison was per-
formed using analysis of variance (one-way ANOVA) followed by Bonferroni’s test.
*Po0.05 or **Po0.01 when compared to vehicle group (Veh).
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measure gastric emptying and intestinal transit, respectively.
2.10.1. Evaluation of gastric emptying (GE)
GE was measured as the amount of marker that remained in
the stomach at the end of the experiment. The stomachs were
individually homogenized with 7 mL of distilled water and cen-
trifuged at 1500g for 20 min. Next, 150 mL of supernatant was
added to 150 mL of 0.01 M NaOH, and the absorbance was mea-
sured at a 560 nm. GE was expressed as a percentage and calcu-
lated as follows: GE%¼100(X100/Y), where X is the absor-
bance of marker solution recovered from the stomach of mice
euthanized 20 min after the administration of marker, and Y is the
mean (n¼6) of the absorbance of marker recovered from the
stomachs of zero control mice (an animal euthanized at 0 min
following administration of the marker).
2.10.2. Evaluation of intestinal transit (IT)
The small intestine was dissected from the pylorus to the
ileocaecal junction to measure IT. The total length of the small
intestine and the distance covered by phenol red solution were
then measured. IT was expressed as a percentage, calculated as
follows: IT¼X/Y100, where X is the distance traveled by phenol
red and Y is the total length of the small intestine.
2.11. Evaluation of toxicity
During the treatment period of the acetic acid-induced gastric
ulcer experiment, the possible toxic effects of HEMR were eval-
uated, using parameters such as mortality and changes in body
mass. At the end of this period, the animals were sacriﬁced and the
adrenal gland, heart, kidney, liver, lung, spleen, ovaries and uterus
were removed and weighed. Thereafter, relative organ weight
[(organ weight/body weight)100] was reported. In addition,
biochemical parameters (alanine aminotransferase (ALT), aspartate
aminotransferase (AST), creatinine and urea levels) were evaluated
in serum samples using a commercial kit (Bioclin/Quibasa, Belo
Horizonte, MG, Brazil).
2.12. Assessment of anti-helicobacter pylori activity
The Minimum Inhibitory Concentration (MIC) was determined
by the agar dilution solid method, according to the re-
commendations of the Clinical Laboratory Standards Institute
(CLSI-Clinical and Laboratory Standards Institute, 2006) and pre-
viously described by Mégraud and Lehours (2007). From stock
extract, solutions of 40 mg/mL were serially diluted. In individual
glasses, 50 μL of each dilution was added to 950 μL of Brucella agar
supplemented with 10% sheeps’ blood, with 45–50 °C of ﬂuid,
reaching concentrations of 2000; 1000; 500; 250; 125; 62.5; 31, 25
and 15.625 μg/ml. The bacterial inoculums were prepared based
on a scale of 0.5 MacFarland turbidity. After the medium solidiﬁ-
cation, 1 mL of bacterial suspension was seeded in each glass with
the diluted extract agar. It was incubated in humidity and micro-
aerophilic optimal conditions, at 35 °C, for 48–72 h. The MIC was
deﬁned as the lowest the concentration of fractions capable of
completely inhibiting bacterial growth. All the experiments were
performed in triplicate.
2.13. Statistical analysis
The results were expressed as mean7standard error of the
mean (SEM) with 6 animals per group. Statistical signiﬁcance was
determined using one- or two-way analysis of variance (ANOVA),
when applicable, followed by Bonferroni’s test using Graph-Pad
5.0 software (GraphPad software, San Diego, CA, USA). Differenceswere considered to be signiﬁcant when po0.05.3. Results and discussion
Acetic acid-induced chronic gastric ulcer was used as an ex-
perimental model to determine the gastric healing effect of the
hydroalcoholic extract obtained from aerial parts of M. robusta
(HEMR). This model was used because it closely resembles chronic
ulcers in humans, particularly in the healing process (Okabe and
Pfeiffer, 1972). In this assay, oral administration of HEMR (10 mg/
kg) or omeprazole (20 mg/kg), twice daily for seven days, pro-
moted reductions in the gastric ulcer area of 53% and 45%, re-
spectively, when compared to the ulcerated vehicle group
(120.078.3 mm2) (Fig 1A). Accordingly, in the tissue observation
it was possible verify that the instillation of acetic acid induced
extensive and deep damage in the gastric mucosa (Fig. 2A), char-
acterized by the single-layered regenerating epithelium originat-
ing from the marginal epithelium of the ulcer and extended over
the granulation tissue in the prolonged ulcer base (Fig. 2D). On the
other hand, the regeneration of gastric mucosa promoted by
omeprazole (20 mg/kg) or HEMR (10 mg/kg) was evidenced by
contraction of the ulcer base and by regenerating glands appeared
in the ulcer margin (Fig. 2E and F, respectively).
Studies of healing properties of substances or extracts are
needed, even though the gastroprotective effect has been proven
(Vasconcelos et al., 2008). For example, ascorbic acid prevents
gastric lesions induced by ethanol (Potrich et al., 2010) or in-
domethacin (Koc et al., 2008) but does not promote the healing of
gastric ulcers induced by acetic acid (da Silva et al., 2013; Potrich
et al., 2010) therefore it is not clinically used for the treatment of
peptic ulcers. Andrade et al. (2007 and 2008) demonstrated the
gastroprotective activity of M. robusta, but healing activity was not
evaluated. In this context, the conﬁrmation of HEMR healing ac-
tivity using the chronic ulcer model induced by acetic acid was
important.
PAS histochemical staining is a technique used to detect the
presence of macromolecules typically found in the mucus, such as
glycoproteins, proteoglycans and glycogen, which protect the
gastric mucosa. As observed in Fig. 3A, the PAS staining in the
stomach from animals treated with HEMR (10 mg/kg) was in-
creased by 37.6% when compared to ulcerated vehicle group (Veh:
3.770.51012 pixels/ﬁeld). Microscopic observations of the PAS
staining in gastric mucosa from rats treated with vehicle, ome-
prazole (20 mg/kg) or HEMR (10 mg/kg) are represented in Fig. 3B,
C and D, respectively. This ﬁnding implies that the healing effect
Fig. 2. Representative macroscopic photograph and histological hematoxylin/eosin appearance of site of 80% acetic acid induced-gastric ulcer. The rats were treated orally
daily for 7 days with vehicle (water plus 1% tween, 1 ml/kg – panels A and D), omeprazole (20 mg/kg – panels B and E) or HEMR (10 mg/kg – panels C and F). Histological
section increased by 16 , m indicate margin of ulcer, b indicate base of ulcer and arrows indicate site of the ulcer.
Fig. 3. Effect of HEMR on staining for mucin-like glycoproteins (PAS) in 80% acetic acid induced-gastric ulcer in rats (Panel A). Representative images of groups orally treated
with vehicle (water plus 1% tween, 1 ml/kg; Panels B), omeprazole (20 mg/kg; Panels B) or HEMR (10 mg/kg; Panels C) for 7 days after. Panels B–D: magniﬁcation¼ 400 .
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an important protective factor in the gastric tissue, which helps
regenerate gastric mucosa, mainly through its lubricant action.
Moreover, the mucus layer reduces physical abrasion in gastric
mucosa and provides an effective protection against gastric acid,
bacteria, luminal toxins, and other xenobiotics (Laine et al., 2008).
Gastric ulcer healing is a complex and dynamic genetically
programmed process that includes cell proliferation, re-epithelia-
lization, granulation tissue formation, angiogenesis, cell interac-
tion, extracellular matrix deposition and tissue remodeling (Tar-
nawski, 2005). It is well-established that myoﬁbroblasts are an
important component of wound healing (Chai et al., 2007), re-
sponsible for extracellular matrix production, morphogenesis and
the inﬂammatory process related to tissue repair (Hinz, 2010;
Kemény et al., 2013; Mutoh et al., 2010). In this context, data ob-
tained from previous studies showed that ﬁbroblasts have an
important role in the gastric and esophageal ulcer healing in mice
and rats (Chai et al., 2007; Konturek et al., 1993; Nishida et al.,
2006). In this way, murine ﬁbroblast L929 (NCTC clone 929) cells
were used as an alternative in vitro model to conﬁrm the cell
proliferation effect of HEMR. Furthermore, taking into account that
L929 ﬁbroblasts are recommended by ISO 10993-5 for cytotoxicity
tests (ISO, 1999), the cytotoxicity of HEMR was also evaluated.
Based on the results obtained from the MTT assay, no cytotoxicity
signal has been found after 24 h of incubation of L929 cells with
HEMR (1–100 mg/ml) (Fig. 4). Furthermore, as observed in Fig. 4C,
HEMR was able to cover scratched wound areas made on the L929
cell monolayer. The enhancement of proliferation and coverage of
scratched wounds by HEMR at 0.1 mg/mL and 1 mg/mL was found
to be 70% and 72%, respectively, compared with the negative
control (Fig. 5). Fibroblast cell cultures have been proposed as a
suitable method for testing wound healing activity in vitro (Abe
et al., 2000), and the data obtained here reinforce the healing
potential of M. robusta.
The generation of reactive oxygen species (ROS) and oxidative
damage is crucial step in the pathogenesis of gastric ulcer (Naito
et al., 2014). For this reason, we determined the ability of HEMR to
act in favor of antioxidant defenses such as GSH, antioxidant en-
zymes (SOD and CAT), and as a ROS scavenger. Similar to what is
described by Maria-Ferreira et al. (2014), we observed that acetic
acid instillation promotes a decrease in GSH levels and in SOD
activity by 42% and 71%, respectively, when compared with normal
non-ulcerated stomach (474.5742.1 mg of GSH/g of tissue and
1.770.3 U SOD/mg of protein) (Table 1). As expected, the acetic
acid-induced ulcer markedly reduced the CAT activity and in-
creased lipid peroxidation (an important biomarker of oxidative
damage) in gastric tissues by 92% and 74%, when compared withFig. 4. Effects of HEMR on the cell viability of L929 ﬁbroblasts as measured by MTT
assay. L929 cells were treated with different concentrations of HEMR. After in-
cubation for 24 h MTT assay was performed. The results represent mean7SEM in
triplicated experiments. Statistical comparison was performed using analysis of
variance (one-way ANOVA) followed by Bonferroni’s test. #Po0.05 compared to
basal group.normal values (3.170.01 mmol de H2O2/min/mg of tissue and
7.370.5 mmol LOOH/mg of tissue) (Table 1). On the other hand,
treatment with HEMR (10 mg/kg) was able to restore the GSH
level, SOD and CAT activity and LOOH content to similar levels to
the not ulcerated group (naive group). Animals treated with
omeprazole (20 mg/kg) showed an increase in CAT activity and a
decrease in LOOH content to 2.070.7 mmol/min/mg of tissue and
7.470.4 mmol LOOH/mg of tissue, respectively, when compared
with the ulcerated vehicle group (Table 1). The in vitro DPPH ra-
dical scavenging proﬁle and cytoprotective effect against H2O2
(200 mM) presented by HEMR was also evaluated, and the results
showed the scavenging effect of the extract at 10 and 100 mg/ml by
36% and 85%, respectively, compared to the vehicle group
(53.970.4 mM of DPPH, Fig. 6A) and highlighted the cytoprotec-
tive activity of HEMR at 0.1, 1, 10 and 100 mg/ml in L929 cells ex-
posed to H2O2 (Fig. 6B). These ﬁndings clearly reinforce that the
reduction in oxidative damage is correlated with the antioxidant
properties of M. robusta, including scavenger activity. These effects
can contribute to the gastric healing presented by M. robusta. In
addition, this is the ﬁrst scientiﬁc evidence of the intracellular
redox status during the healing process promoved by an extract
from a Maytenus ssp.
Leukocyte migration to the site of the lesion is an important
event in the healing process, and neutrophils are the ﬁrst cells to
arrive, these cells being crucial for the onset of the gastric in-
ﬂammatory process (Santin et al., 2013). However, the persistence
of neutrophils in the regenerated epithelium after an incomplete
healing process is a key event for ulcer recurrence (Kangwan et al.,
2014). Moreover, there is plenty of evidence linking the catalytic
activity of MPO, a cationic enzyme present in the azurophilic
granules of neutrophils, and the neutrophil role in the oxidative
stress by ROS production (Martin-Ventura et al., 2012; Pattison
et al., 2012; Yoshida et al., 2014). For this reason, the MPO activity
measurement is commonly used as an indirect indicator of neu-
trophil migration to tissue. As shown in Fig. 7A, the MPO activity
was increased by 51% in damaged stomachs when compared to
non-ulcerated group (Naive: 7.371.3 mO.D./mg of protein), this
result conﬁrms the hypothesis of increased neutrophil migration
in the occurrence of ulcer. However, oral administration of ome-
prazole (20 mg/kg) or HEMR (10 mg/kg) was able to reverse the
increased myeloperoxidase activity in the stomach of acetic acid-
ulcerated rats to the basal level. In view of this result, the next step
was to evaluate whether this effect is mediated by neutrophil in-
ﬂux blockage or by direct inhibition of enzyme activity. To answer
this question, a sample of homogenate obtained from ulcerated
tissue (vehicle-treated animal) was incubated with vehicle or
HEMR (1, 10 or 100 mg/mL) and MPO activity was measured again.
Interestingly, HEMR at 10 and 100 mg/mL inhibited the MPO ac-
tivity in vitro by 51% and 50% (Fig. 7B), and proved that the extract
can act directly in the enzymatic reaction and therefore reduce
ROS generation mediated by neutrophils. In addition, to study the
effects HEMR on neutrophil trafﬁcking, we used carrageenan-in-
duced inﬂammation in the air pouch model. The results showed
that HEMR treatment (10 mg/kg) does not inhibit the migration of
neutrophils to the air pouch, compared to vehicle group (Veh:
89.677.6106 cells/mL) (Table 2). Thus, the reduction in MPO
activity described above is probably related to enzyme inhibition,
and not to a reduction in neutrophil migration.
Continuing with the evaluation of the healing mechanisms, we
carried out hypersecretion induced by pylorus ligature. The data
obtained show that HEMR (10 mg/kg, i.d.) does not promote
changes in volume, pH, total acidity or pepsin activity when
compared to the vehicle group (Table 3). As expected, omeprazole
increased the pH to 6.770.20 and reduced gastric volume, total
acidity and peptic activity by 63%, 89% and 41%, respectively, when
compared to the vehicle group (Veh: 1.570.07 pH value;
Fig. 5. Effects of HEMR on cell migration in the in vitro scratch assay. A ﬁbroblast L929 layer subjected to scratch and treated with HEMR 0.1 mg/ml, HEMR 1 mg/ml and with
vehicle. In Panel A: Images captured at 100 magniﬁcation at hour 0 and 30 after incubation. In Panel B: Measurement the rate of migration by quantifying the total
distance that the cells moved from the edge of the scratch toward the center. The results represent mean7SEM in triplicated experiments. Statistical comparison was
performed using analysis of variance (two-way ANOVA) followed by Bonferroni’s test. nnnPo0.001 and nnPo0.01 compared to the matched-time vehicle group.
Table 1
Effects of HEMR in GSH and LOOH levels and SOD and CAT activity.
Group SOD (U/mg of protein) CAT (mmol/min/mg protein) GSH (lg/g of tissue) LOOH (mmol/g of tissue)
Naive 1.770.3 3.170.01 475.0735.5 20.671.3
Vehicle (0.1 ml/100 g, p.o.) 0.570.1# 0.270.09# 307.8737.8### 35.872.9#
Omeprazole (20 mg/kg, p.o.) 0.4870.1# 2. 070.7n 282.6724.8### 21.771.2n
HEMR (10 mg/kg, p.o.) 1.570.3n 1.070.4n 452.2732.7n 24.372.4n
Values are mean7S.E.M. (n¼6).
# Po0.01.
### Po0.001 when compared with the naive group.
n Po0.01 when compared with the vehicle group.
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4 h) (Table 3). Thus, based on our data, we can infer that gastric
acid inhibition is not related to the mechanism of gastric ulcer
healing presented by HEMR at the dose evaluated. On the other
hand, previous studies conducted by Andrade et al. (2007) showed
that HEMR at doses of 50, 250 or 500 mg/kg present gastric acid
antisecretory effect. The present study therefore shows that HEMR
at a dose of 10 mg/kg displays an interesting healing effect,
without interfering in the gastric secretion parameters. Consider-
ing the side effects linked to antisecretory therapy, is interesting
that the extract keep its antiulcer potential in the absence of an-
tisecretory effect. In addition, an herbal formulation that promotes
gastroprotection and gastric ulcer healing and not alter gastric acid
secretion can be used in parallel to classical therapies. Also, in
relation to anti- H. Pylori activity, HEMR incubation at all the tested
concentrations did not present considerable activity against thisbacterium (data not shown).
Concerning the gastrointestinal motility experiments, GE and IT
of semisolid phenol red after 15 min in control mice was
70.672.2% and 64.673.1%, respectively; oral treatment with
HEMR (10 mg/kg) did not alter GE or IT. Atropine, the positive
control for the test, reduced GE and IT by 24% and 68%, respec-
tively, when compared to the vehicle group (Table 4). Thus, it was
found that HEMR (10 mg/kg) did not alter gastrointestinal motility.
The GE rate and IT are related to a neurohumoral mechanism, and
the endogenous neurotransmitter acetylcholine (Ach) is described
as the major mediator of gastrointestinal motility (Sagar et al.,
2005). We can therefore infer that the change in the cholinergic
pathway is not involved in the gastric healing of the extract.
Phytochemical analysis performed with extract fromM. robusta
demonstrated mainly the presence of pentacyclic triterpenes, i.e.
friedelin, β-friedelinol, 3-oxo-21β-H-hop-22(29)-ene, 3,4-seco-
Fig. 6. Effects of HEMR on the ability to scavenge the free-radical DPPH and in to protect L929 cells against hydrogen peroxide-induced cytotoxicity. Panel A shows the
scavenging of DPPH radical by HEMR (1–1000 μg/ml) or ascorbic acid (AA, 50 μg/ml) in vitro and Panel B shows the protective effect of HEMR against H2O2-induced
cytotoxicity in L929 cells. Cells were co-treated with HEMR and 200 μM H2O2 for 2 h. The results are expressed as mean7S.E.M, in triplicated experiments. Statistical
comparison was performed using analysis of variance (one-way ANOVA) followed by Bonferroni’s test. nPo0.05 or nnnPo0.001 when compared to vehicle group (Veh).
Table 2
Effects of HEMR in leukocyte migration.
Group Total leukocytes Neutrophils
(106/mL) (106/mL)
Naive 0.970.87 0.770.5
Vehicle (1 ml/kg) 89.677.6### 83.474.9###
Indomethacin (30 mg/kg, p.o) 12.975.4nnn 11.971.2nnn
HEMR (10 mg/kg, p.o) 84.679.2 83.476.6
Values are mean7S.E.M. (n¼6).
### Po0.001 when compared with the naive group.
nnn Po0.001 when compared with the vehicle group.
Table 3
Effects of HEMR on gastric acid secretion.
Group pH Volume (mL) Acidity (mEq
[Hþ])
Pepsin activity
(lM of tirosin/
4 h)
Vehicle (1 mL/
kg, i.d.)
1.570.07 7.970.47 72.172.20 1.170.07
Omeprazole
(20 mg/kg, p.
o.)
6.770.20n 2.970.26n 7.973.00n 0.670.06n
HEMR (10 mg/
kg, i.d.)
2.270.34 6.670.73 54.379.50 0.970.10
Values are mean7S.E.M. (n¼6).
n Po0.05 when compared with the vehicle group.
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seco-21β-H-hop-22(29)-en-3-oic acid, 3,4-seco-friedelan-3-oic
acid (Sousa et al., 2012), 3,15-dioxo-21alpha-hydroxy friedelane
(Andrade et al., 2008; Niero et al., 2006). Pentacyclic triterpenes
are secondary metabolites widely distributed in nature, and the
gastroprotective and antiulcer activities are one of the most re-
ported biological effects of these compounds. These effects are
attributed to its ability to strengthen the defense factors in gastric
mucosa, e.g. by stimulating mucus synthesis or maintaining the
prostaglandin contents of gastric mucosa at high levels (Klein
et al., 2012; Lewis and Hanson, 1991). Moreover, the antiulcer ef-
fect of 3,15-dioxo-21alpha-hydroxy friedelane isolated from hy-
droalcoholic M. robusta extract was reported by De Andrade et al.
(2008). In contrast, Queiroga et al. (2000) showed that triterpenes
friedelin and friedelanol was not displayed gastroprotective effect.
In addition, is important to emphasize that the presence of other
compounds may contribute to antiulcer effect of M. robusta, in-
cluding steroids and ﬂavonoids; compounds previously identiﬁed
by thin layer chromatography in samples from M. robusta extract
by Niero et al. (2001).
It is also important to mention that the oral administration of
HEMR not produced any sign of acute toxicity in the animals. Over
the 7 days following the oral administration HEMR (10 mg/kg),
none of the animals died and no signiﬁcant changes in organ
weight, hepatic enzymes (AST and ALT) or renal functions (crea-
tinine and urea) were observed at the end of this period (data not
shown). Previous studies by our group demonstrated that me-
thanol extract of M. robusta presents genotoxicity but not clasto-
genicity at 250 or 500 mg/kg, when administered orallyFig. 7. Effects of HEMR on the myeloperoxidase (MPO) activity. Panel A shows the MPO activity in normal non-ulcerated rats (Naive), vehicle- (Veh, 1 ml/kg), omeprazole-
(Ome, 20 mg/kg) or HEMR- (10 mg/kg) treated- rats and Panel B shows the HEMR effects in MPO activity in vitro by its incubation at 1, 10 and 100 μg/ml in a sample with
high level of MPO activity. The results are expressed as mean7S.E.M, (n¼8). Statistical comparison was performed using analysis of variance (one-way ANOVA) followed by
Bonferroni’s test. ###Po0.001, when compared to non-ulcerated groups (N) and nPo0.05 and nnPo0.01 when compared to vehicle group (Veh).
Table 4
Effects of HEMR on gastric emptying and intestinal transit.
Group Gastric emptying (%) Intestinal transit (%)
Vehicle (1 mL/kg, i.d.) 64.673.1 70.672.2
Atropine (3 mg/kg, s.c.) 21.075.2n 53.775.9nnn
HEMR (10 mg/kg, i.d.) 54.875.3 69.671.2
Values are mean7S.E.M. (n¼6).
n Po0.05 when compared with the vehicle group.
nnn Po0.001 when compared with the vehicle group.
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or clastogenic effects were observed at the dose of 50 mg/kg.
In conclusion, the data obtained here showed that M. robusta
has evident ulcer healing, mainly through the strengthening of
protective factors of the gastric mucosa, such as mucus layer, an-
tioxidant defenses and cell proliferation. Taking into account the
advantages in cultivation and harvesting of M. robusta it is plau-
sible to conclude that hydroalcoholic extract obtained from aerial
parts of M. robusta is an interesting source for the development of
a new phytotherapeutic formulation to treat gastric ulcer.Acknowledgments
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